GlassScriptPhysician profile
Remington Farley
NPI 1407476120
$1,730.80
in general payments reported to CMS, 2019-2025
12 companies · $587 in 2025
The $587 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $245 · 2023: $450 · 2024: $448 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,349 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,348.76 |
| Entertainment | $136.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $379.58 | 2022-2025 | Lithovue, Spaceoar Vue System - 10ml, General - Female Sui |
| Medtronic, INC. | $172.65 | 2024-2025 | Interstim |
| Photocure INC | $141.26 | 2025 | Cysview |
| Merck Sharp & Dohme LLC | $136.95 | 2024-2025 | Keytruda, Welireg |
| Edap Technomed INC | $136.63 | 2025 | |
| Olympus America INC. | $133.72 | 2022 | |
| Sumitomo Pharma America, INC. | $127.00 | 2023 | Orgovyx |
| Urogen Pharma, INC. | $121.84 | 2024 | |
| Astellas Pharma US INC | $115.67 | 2023 | |
| Abbvie INC. | $104.99 | 2024 | |
| Blue Earth Diagnostics | $96.97 | 2025 | Posluma |
| Coloplast Corp | $63.54 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Remington Farley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.